{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:33:19Z","timestamp":1784827999101,"version":"3.55.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-024-01832-2","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T12:01:42Z","timestamp":1727438502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Analysis of early effects of human APOE isoforms on Alzheimer\u2019s disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE"],"prefix":"10.1186","volume":"22","author":[{"given":"Metin","family":"Yesiltepe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Tambini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"d\u2019Abramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Giliberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"D\u2019Adamio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"9","key":"1832_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, et al. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318.","journal-title":"Nat Rev Neurol."},{"key":"1832_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.arr.2017.06.002","volume":"37","author":"P Huebbe","year":"2017","unstructured":"Huebbe P, Rimbach G. Evolution of human apolipoprotein E (APOE) isoforms: gene structure, protein function and interaction with dietary factors. Ageing Res Rev. 2017;37:146\u201361.","journal-title":"Ageing Res Rev"},{"issue":"4","key":"1832_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1086\/303070","volume":"67","author":"SM Fullerton","year":"2000","unstructured":"Fullerton SM, et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet. 2000;67(4):881\u2013900.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1832_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/0003-9861(85)90704-0","volume":"239","author":"HJ Kayden","year":"1985","unstructured":"Kayden HJ, Maschio F, Traber MG. The secretion of apolipoprotein E by human monocytederived macrophages. Arch Biochem Biophys. 1985;239(2):388\u201395.","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"1832_CR5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.biocel.2004.10.004","volume":"37","author":"JR Gee","year":"2005","unstructured":"Gee JR, Keller JN. Astrocytes: regulation of brain homeostasis via apolipoprotein E. Int J Biochem Cell Biol. 2005;37(6):1145\u201350.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1\u20132","key":"1832_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0304-3940(94)91074-X","volume":"175","author":"HL West","year":"1994","unstructured":"West HL, Rebeck GW, Hyman BT. Frequency of the apolipoprotein E \u03b52 allele is diminished in sporadic Alzheimer disease. Neurosci Lett. 1994;175(1\u20132):46\u20138.","journal-title":"Neurosci Lett."},{"issue":"16","key":"1832_CR7","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA. 1997;278(16):1349\u201356.","journal-title":"JAMA"},{"issue":"10","key":"1832_CR8","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.1073\/pnas.081612998","volume":"98","author":"E Kojro","year":"2001","unstructured":"Kojro E, et al. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the \u03b1-secretase ADAM 10. Proc Natl Acad Sci. 2001;98(10):5815\u201320.","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"1832_CR9","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.bbalip.2010.05.002","volume":"1801","author":"S Gr\u00f6sgen","year":"2010","unstructured":"Gr\u00f6sgen S, et al. Role of amyloid beta in lipid homeostasis. Biochim Biophys Acta Mol Cell Biol Lipids. 2010;1801(8):966\u201374.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"20","key":"1832_CR10","doi-asserted-by":"publisher","first-page":"11735","DOI":"10.1073\/pnas.1635130100","volume":"100","author":"JM Cordy","year":"2003","unstructured":"Cordy JM, et al. Exclusively targeting \u03b2-secretase to lipid rafts by GPI-anchor addition up-regulates \u03b2-site processing of the amyloid precursor protein. Proc Natl Acad Sci. 2003;100(20):11735\u201340.","journal-title":"Proc Natl Acad Sci"},{"issue":"38","key":"1832_CR11","doi-asserted-by":"publisher","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","volume":"269","author":"MJ LaDu","year":"1994","unstructured":"LaDu MJ, et al. Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem. 1994;269(38):23403\u20136.","journal-title":"J Biol Chem"},{"issue":"2","key":"1832_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3233\/JAD-2010-100141","volume":"21","author":"MJ Sharman","year":"2010","unstructured":"Sharman MJ, et al. APOE genotype results in differential effects on the peripheral clearance of amyloid-\u03b2 42 in APOE knock-in and knock-out mice.\u00a0J Alzheimers Dis. 2010;21(2):403\u20139.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1832_CR13","doi-asserted-by":"publisher","first-page":"e13033","DOI":"10.1111\/acel.13033","volume":"18","author":"MD Tambini","year":"2019","unstructured":"Tambini MD, Yao W, D\u2019Adamio L. Facilitation of glutamate, but not GABA, release in familial Alzheimer\u2019s APP mutant Knock-in rats with increased beta-cleavage of APP. Aging Cell. 2019;18(6):e13033.","journal-title":"Aging Cell"},{"issue":"10","key":"1832_CR14","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1073\/pnas.89.10.4471","volume":"89","author":"JA Piedrahita","year":"1992","unstructured":"Piedrahita JA, et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.\u00a0Proc Natl Acad Sci. 1992;89(10):4471\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"29","key":"1832_CR15","doi-asserted-by":"publisher","first-page":"17972","DOI":"10.1074\/jbc.272.29.17972","volume":"272","author":"PM Sullivan","year":"1997","unstructured":"Sullivan PM, et al. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem. 1997;272(29):17972\u201380.","journal-title":"J Biol Chem"},{"issue":"15","key":"1832_CR16","doi-asserted-by":"publisher","first-page":"8262","DOI":"10.3390\/ijms22158262","volume":"22","author":"Y Wu","year":"2021","unstructured":"Wu Y, et al. Features of lipid metabolism in humanized ApoE knockin rat models. Int J Mol Sci. 2021;22(15):8262.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1832_CR17","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nprot.2006.120","volume":"1","author":"RM Deacon","year":"2006","unstructured":"Deacon RM. Housing, husbandry and handling of rodents for behavioral experiments. Nat Protoc. 2006;1(2):936\u201346.","journal-title":"Nat Protoc"},{"issue":"3","key":"1832_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/dev.1041","volume":"39","author":"IQ Whishaw","year":"2001","unstructured":"Whishaw IQ, et al. Accelerated nervous system development contributes to behavioral efficiency in the laboratory mouse: a behavioral review and theoretical proposal. Dev Psychobiol. 2001;39(3):151\u201370.","journal-title":"Dev Psychobiol"},{"issue":"7210","key":"1832_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature07200","volume":"455","author":"A Kepecs","year":"2008","unstructured":"Kepecs A, et al. Neural correlates, computation and behavioural impact of decision confidence. Nature. 2008;455(7210):227\u201331.","journal-title":"Nature"},{"issue":"6","key":"1832_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/09658211.2017.1410849","volume":"26","author":"A Jemstedt","year":"2018","unstructured":"Jemstedt A, Schwartz BL, Jonsson FU. Ease-of-learning judgments are based on both processing fluency and beliefs. Memory. 2018;26(6):807\u201315.","journal-title":"Memory"},{"issue":"15","key":"1832_CR21","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1523\/JNEUROSCI.4050-15.2016","volume":"36","author":"BB Bartelle","year":"2016","unstructured":"Bartelle BB, Barandov A, Jasanoff A. Molecular fMRI. J Neurosci. 2016;36(15):4139\u201348.","journal-title":"J Neurosci"},{"issue":"1","key":"1832_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2047-9158-3-6","volume":"3","author":"ER Zimmer","year":"2014","unstructured":"Zimmer ER, et al. In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals. Transl Neurodegener. 2014;3(1):6.","journal-title":"Transl Neurodegener"},{"issue":"3","key":"1832_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/13506129.2014.926267","volume":"21","author":"A Leuzy","year":"2014","unstructured":"Leuzy A, et al. Use of amyloid PET across the spectrum of Alzheimer\u2019s disease: clinical utility and associated ethical issues. Amyloid. 2014;21(3):143\u20138.","journal-title":"Amyloid"},{"issue":"5","key":"1832_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1017\/cjn.2014.15","volume":"41","author":"ER Zimmer","year":"2014","unstructured":"Zimmer ER, et al. Developments in Tau PET imaging. Can J Neurol Sci. 2014;41(5):547\u201353.","journal-title":"Can J Neurol Sci"},{"issue":"2\u20133","key":"1832_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbadis.2004.08.010","volume":"1739","author":"A Andreadis","year":"2005","unstructured":"Andreadis A. Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim Biophys Acta. 2005;1739(2\u20133):91\u2013103.","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"1832_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0169-328X(99)00079-0","volume":"68","author":"C Janke","year":"1999","unstructured":"Janke C, et al. Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders. Brain Res Mol Brain Res. 1999;68(1\u20132):119\u201328.","journal-title":"Brain Res Mol Brain Res"},{"issue":"5395","key":"1832_CR27","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","volume":"282","author":"M Hong","year":"1998","unstructured":"Hong M, et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science. 1998;282(5395):1914\u20137.","journal-title":"Science"},{"issue":"5","key":"1832_CR28","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1471-4159.2009.05869.x","volume":"108","author":"J Hanes","year":"2009","unstructured":"Hanes J, et al. Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies. J Neurochem. 2009;108(5):1167\u201376.","journal-title":"J Neurochem"},{"issue":"6","key":"1832_CR29","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cne.21867","volume":"511","author":"P McMillan","year":"2008","unstructured":"McMillan P, et al. Tau isoform regulation is region- and cell-specific in mouse brain. J Comp Neurol. 2008;511(6):788\u2013803.","journal-title":"J Comp Neurol"},{"issue":"11","key":"1832_CR30","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","volume":"40","author":"RW Mahley","year":"1999","unstructured":"Mahley RW, Huang Y, Rall SC. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes. J Lipid Res. 1999;40(11):1933\u201349.","journal-title":"J Lipid Res."},{"issue":"1","key":"1832_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-2275(20)33334-4","volume":"40","author":"RW Mahley","year":"1999","unstructured":"Mahley RW, Ji Z-S. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res. 1999;40(1):1\u201316.","journal-title":"J Lipid Res."},{"issue":"37","key":"1832_CR32","doi-asserted-by":"publisher","first-page":"12867","DOI":"10.1021\/bi980828m","volume":"37","author":"S Lund-Katz","year":"1998","unstructured":"Lund-Katz S, et al. Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction. Biochemistry. 1998;37(37):12867\u201374.","journal-title":"Biochemistry"},{"issue":"41","key":"1832_CR33","doi-asserted-by":"publisher","first-page":"26388","DOI":"10.1074\/jbc.273.41.26388","volume":"273","author":"Y Huang","year":"1998","unstructured":"Huang Y, et al. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia *. J Biol Chem. 1998;273(41):26388\u201393.","journal-title":"J Biol Chem"},{"issue":"25","key":"1832_CR34","doi-asserted-by":"publisher","first-page":"14791","DOI":"10.1074\/jbc.271.25.14791","volume":"271","author":"PCN Rensen","year":"1996","unstructured":"Rensen PCN, van Berkel TJC. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J Biol Chem. 1996;271(25):14791\u20139.","journal-title":"J Biol Chem"},{"issue":"3","key":"1832_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJM196701192760305","volume":"276","author":"DS Fredrickson","year":"1967","unstructured":"Fredrickson DS, Levy RI, Lees RS. Fat transport in lipoproteins \u2014 an integrated approach to mechanisms and disorders.\u00a0N Engl J Med. 1967;276(3):148\u201356.","journal-title":"N Engl J Med"},{"issue":"2","key":"1832_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/0014-5793(75)81125-2","volume":"56","author":"G Utermann","year":"1975","unstructured":"Utermann G, Jaeschke M, Menzel J. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins. FEBS lett. 1975;56(2):352\u20135.","journal-title":"FEBS lett"},{"issue":"4","key":"1832_CR37","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1021\/bi00507a059","volume":"20","author":"VI Zannis","year":"1981","unstructured":"Zannis VI, Breslow JL. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry. 1981;20(4):1033\u201341.","journal-title":"Biochemistry"},{"issue":"4852","key":"1832_CR38","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240(4852):622\u201330.","journal-title":"Science"},{"issue":"1","key":"1832_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.ATV.8.1.1","volume":"8","author":"J Davignon","year":"1988","unstructured":"Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8(1):1\u201321.","journal-title":"Arteriosclerosis."},{"issue":"9","key":"1832_CR40","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/iub.1314","volume":"66","author":"MC Phillips","year":"2014","unstructured":"Phillips MC. Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life. 2014;66(9):616\u201323.","journal-title":"IUBMB Life"},{"issue":"2","key":"1832_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2011.10.011","volume":"220","author":"J Gustavsson","year":"2012","unstructured":"Gustavsson J, et al. Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women. Atherosclerosis. 2012;220(2):486\u201392.","journal-title":"Atherosclerosis"},{"issue":"5","key":"1832_CR42","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1016\/S0021-9258(18)34954-8","volume":"257","author":"KH Weisgraber","year":"1982","unstructured":"Weisgraber KH, Innerarity TL, Mahley RW. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem. 1982;257(5):2518\u201321.","journal-title":"J Biol Chem"},{"issue":"5","key":"1832_CR43","doi-asserted-by":"publisher","first-page":"e0263546","DOI":"10.1371\/journal.pone.0263546","volume":"17","author":"H Pham","year":"2022","unstructured":"Pham H, Yin T, D\u2019Adamio L. Initial assessment of the spatial learning, reversal, and sequencing task capabilities of knock-in rats with humanizing mutations in the A\u03b2-coding region of App. PLoS One. 2022;17(5):e0263546.","journal-title":"PLoS One"},{"issue":"6","key":"1832_CR44","doi-asserted-by":"publisher","first-page":"e13033","DOI":"10.1111\/acel.13033","volume":"18","author":"MD Tambini","year":"2019","unstructured":"Tambini MD, Yao W, D\u2019Adamio L. Facilitation of glutamate, but not GABA, release in familial Alzheimer\u2019s APP mutant knock-in rats with increased \u03b2-cleavage of APP. Aging Cell. 2019;18(6):e13033.","journal-title":"Aging Cell"},{"key":"1832_CR45","doi-asserted-by":"publisher","first-page":"1040576","DOI":"10.3389\/fnagi.2022.1040576","volume":"14","author":"M Yesiltepe","year":"2022","unstructured":"Yesiltepe M, et al. Late-long-term potentiation magnitude, but not Abeta levels and amyloid pathology, is associated with behavioral performance in a rat knock-in model of Alzheimer disease. Front Aging Neurosci. 2022;14:1040576.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"1832_CR46","doi-asserted-by":"publisher","first-page":"104868","DOI":"10.1016\/j.jbc.2023.104868","volume":"299","author":"MD Tambini","year":"2023","unstructured":"Tambini MD, et al. Abeta43 levels determine the onset of pathological amyloid deposition. J Biol Chem. 2023;299(7):104868.","journal-title":"J Biol Chem"},{"issue":"3","key":"1832_CR47","doi-asserted-by":"publisher","first-page":"101089","DOI":"10.1016\/j.jbc.2021.101089","volume":"297","author":"T Yin","year":"2021","unstructured":"Yin T, et al. A familial Danish dementia rat shows impaired presynaptic and postsynaptic glutamatergic transmission. J Biol Chem. 2021;297(3):101089.","journal-title":"J Biol Chem"},{"key":"1832_CR48","doi-asserted-by":"publisher","first-page":"100089","DOI":"10.1074\/jbc.RA120.016395","volume":"296","author":"S Ren","year":"2021","unstructured":"Ren S, et al. TNF-alpha-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer\u2019s disease pathology in young Trem 2(R47H) rats. J Biol Chem. 2021;296:100089.","journal-title":"J Biol Chem"},{"key":"1832_CR49","doi-asserted-by":"publisher","first-page":"e57513","DOI":"10.7554\/eLife.57513","volume":"9","author":"S Ren","year":"2020","unstructured":"Ren S, et al. Microglia TREM2(R47H) Alzheimer-linked variant enhances excitatory transmission and reduces LTP via increased TNF-alpha levels. Elife. 2020;9:e57513.","journal-title":"Elife"},{"issue":"7","key":"1832_CR50","doi-asserted-by":"publisher","first-page":"104868","DOI":"10.1016\/j.jbc.2023.104868","volume":"299","author":"MD Tambini","year":"2023","unstructured":"Tambini MD, et al. A\u03b243 levels determine the onset of pathological amyloid deposition. J Biol Chem. 2023;299(7):104868.","journal-title":"J Biol Chem"},{"key":"1832_CR51","doi-asserted-by":"publisher","first-page":"1040576","DOI":"10.3389\/fnagi.2022.1040576","volume":"14","author":"M Yesiltepe","year":"2022","unstructured":"Yesiltepe M, et al. Late-long-term potentiation magnitude, but not A\u03b2 levels and amyloid pathology, is associated with behavioral performance in a rat knock-in model of Alzheimer disease. Front Aging Neurosci. 2022;14:1040576.","journal-title":"Front Aging Neurosci"},{"key":"1832_CR52","doi-asserted-by":"crossref","unstructured":"Han X.\u00a0Lipidomics: comprehensive mass spectrometry of lipids.\u00a0Hoboken: Wiley; 2016.","DOI":"10.1002\/9781119085263"},{"issue":"1","key":"1832_CR53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/jnc.13738","volume":"139","author":"JP Palavicini","year":"2016","unstructured":"Palavicini JP, et al. Novel molecular insights into the critical role of sulfatide in myelin maintenance\/function. J Neurochem. 2016;139(1):40\u201354.","journal-title":"J Neurochem."},{"issue":"13","key":"1832_CR54","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/rcm.3595","volume":"22","author":"X Han","year":"2008","unstructured":"Han X, Yang K, Gross RW. Microfluidics-based electrospray ionization enhances the intrasource separation of lipid classes and extends identification of individual molecular species through multi-dimensional mass spectrometry: development of an automated high-throughput platform for shotgun lipidomics. Rapid Commun Mass Spectrom. 2008;22(13):2115\u201324.","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"11","key":"1832_CR55","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1021\/ac900241u","volume":"81","author":"K Yang","year":"2009","unstructured":"Yang K, et al. Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics. Anal Chem. 2009;81(11):4356\u201368.","journal-title":"Anal Chem"},{"key":"1832_CR56","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-1-4939-1258-2_13","volume":"1198","author":"M Wang","year":"2014","unstructured":"Wang M, Han X. Multidimensional mass spectrometry-based shotgun lipidomics. Methods Mol Biol. 2014;1198:203\u201320.","journal-title":"Methods Mol Biol"},{"issue":"11","key":"1832_CR57","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1021\/ac900241u","volume":"81","author":"K Yang","year":"2009","unstructured":"Yang K, et al. Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics.\u00a0Anal Chem. 2009;81(11):4356\u201368.","journal-title":"Anal Chem"},{"issue":"6","key":"1832_CR58","first-page":"6772","volume":"13","author":"C Cai","year":"2021","unstructured":"Cai C, Wen Z, Li L. The relationship between ApoE gene polymorphism and the efficacy of statins controlling hyperlipidemia. Am J Transl Res. 2021;13(6):6772\u20137.","journal-title":"Am J Transl Res"},{"issue":"3\u20134","key":"1832_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3233\/JAD-2000-23-408","volume":"2","author":"B Passer","year":"2000","unstructured":"Passer B, et al. Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer\u2019s amyloid beta protein precursor. J Alzheimers Dis. 2000;2(3\u20134):289\u2013301.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1832_CR60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0022-2836(77)90214-5","volume":"116","author":"DW Cleveland","year":"1977","unstructured":"Cleveland DW, Hwo S-Y, Kirschner MW. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol. 1977;116(2):227\u201347.","journal-title":"J Mol Biol"},{"key":"1832_CR61","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fneur.2013.00083","volume":"4","author":"W Noble","year":"2013","unstructured":"Noble W, et al. The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol. 2013;4:83.","journal-title":"Front Neurol"},{"issue":"1","key":"1832_CR62","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1038\/s41598-018-21596-3","volume":"8","author":"F Biundo","year":"2018","unstructured":"Biundo F, et al. A role for tau in learning, memory and synaptic plasticity. Sci Rep. 2018;8(1):3184.","journal-title":"Sci Rep"},{"issue":"13","key":"1832_CR63","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal I, et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci. 1986;83(13):4913\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"1832_CR64","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/nan.12529","volume":"45","author":"M Tzioras","year":"2019","unstructured":"Tzioras M, et al. Invited review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer\u2019s disease.\u00a0Neuropathol Appl Neurobiol. 2019;45(4):327\u201346.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"1832_CR65","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.conb.2011.08.002","volume":"21","author":"CD Keene","year":"2011","unstructured":"Keene CD, et al. Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer\u2019s disease.\u00a0Curr Opin Neurobiol. 2011;21(6):920\u20138.","journal-title":"Curr Opin Neurobiol"},{"key":"1832_CR66","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1749-6632.2010.05726.x","volume":"1207","author":"PB Gorelick","year":"2010","unstructured":"Gorelick PB. Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann N Y Acad Sci. 2010;1207:155\u201362.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"1832_CR67","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/jnc.13072","volume":"133","author":"LM Tai","year":"2015","unstructured":"Tai LM, et al. modulated A\u03b2-induced neuroinflammation in Alzheimer\u2019s disease: current landscape, novel data, and future perspective. J Neurochem. 2015;133(4):465\u201388.","journal-title":"J Neurochem"},{"issue":"4","key":"1832_CR68","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0306-4522(99)00061-5","volume":"92","author":"P Krzywkowski","year":"1999","unstructured":"Krzywkowski P, et al. Cholinergic systems and long-term potentiation in memory-impaired apolipoprotein E-deficient mice. Neuroscience. 1999;92(4):1273\u201386.","journal-title":"Neuroscience"},{"issue":"9","key":"1832_CR69","doi-asserted-by":"publisher","first-page":"641","DOI":"10.7326\/0003-4819-121-9-199411010-00002","volume":"121","author":"B Kinosian","year":"1994","unstructured":"Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med. 1994;121(9):641\u20137.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1832_CR70","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00401-014-1266-2","volume":"127","author":"E Mart\u00ednez-Morillo","year":"2014","unstructured":"Mart\u00ednez-Morillo E, et al. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer\u2019s disease patients and controls.\u00a0Acta Neuropathol. 2014;127(5):633\u201343.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1832_CR71","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13195-023-01262-1","volume":"15","author":"A Giannisis","year":"2023","unstructured":"Giannisis A, et al. Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer\u2019s disease and mild cognitive impairment. Alzheimers Res Ther. 2023;15(1):119.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"1832_CR72","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jalz.2014.06.015","volume":"10","author":"DM Michaelson","year":"2014","unstructured":"Michaelson DM. APOE \u03b54: the most prevalent yet understudied risk factor for Alzheimer\u2019s disease.\u00a0Alzheimers Dement. 2014;10(6):861\u20138.","journal-title":"Alzheimers Dement"},{"issue":"43","key":"1832_CR73","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","volume":"32","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, et al. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide. J Neurosci. 2012;32(43):15181\u201392.","journal-title":"J Neurosci"},{"issue":"212","key":"1832_CR74","doi-asserted-by":"publisher","first-page":"212ra161","DOI":"10.1126\/scitranslmed.3007000","volume":"5","author":"E Hudry","year":"2013","unstructured":"Hudry E, et al. Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain.\u00a0Sci Transl Med. 2013;5(212):212ra161-212ra161.","journal-title":"Sci Transl Med"},{"issue":"41","key":"1832_CR75","doi-asserted-by":"publisher","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","volume":"30","author":"Y Andrews-Zwilling","year":"2010","unstructured":"Andrews-Zwilling Y, et al. Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J Neurosci. 2010;30(41):13707.","journal-title":"J Neurosci"},{"issue":"1","key":"1832_CR76","doi-asserted-by":"publisher","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","volume":"2","author":"T Wyss-Coray","year":"2012","unstructured":"Wyss-Coray T, Rogers J. Inflammation in Alzheimer disease\u2014a brief review of the basic science and clinical literature.\u00a0Cold Spring Harb Perspect Med\u00a02012;2(1):a006346.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"1832_CR77","doi-asserted-by":"publisher","first-page":"e183597","DOI":"10.1001\/jamanetworkopen.2018.3597","volume":"1","author":"Q Tao","year":"2018","unstructured":"Tao Q, et al. Association of chronic low-grade inflammation with risk of Alzheimer disease in ApoE4 carriers. JAMA Netw Open. 2018;1(6):e183597\u2013e183597.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"1832_CR78","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","volume":"60","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, et al. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia. 2012;60(4):559\u201369.","journal-title":"Glia"},{"issue":"9","key":"1832_CR79","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/cns.12720","volume":"23","author":"G-Z Sun","year":"2017","unstructured":"Sun G-Z, et al. Hippocampal synaptic and neural network deficits in young mice carrying the human 4 gene.\u00a0CNS Neurosci Ther. 2017;23(9):748\u201358.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"1832_CR80","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1326-8-16","volume":"8","author":"O Liraz","year":"2013","unstructured":"Liraz O, Boehm-Cagan A, Michaelson DM. ApoE4 induces A\u03b242, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.\u00a0Mol Neurodegener. 2013;8(1):16.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1832_CR81","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-019-0324-6","volume":"14","author":"R Najm","year":"2019","unstructured":"Najm R, Jones EA, Huang Y. Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer\u2019s disease.\u00a0Mol Neurodegener. 2019;14(1):24.","journal-title":"Mol Neurodegener"},{"issue":"17","key":"1832_CR82","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1097\/00001756-200412030-00020","volume":"15","author":"BL Trommer","year":"2004","unstructured":"Trommer BL, et al. ApoE isoform affects LTP in human targeted replacement mice. Neuroreport. 2004;15(17):2655\u20138.","journal-title":"Neuroreport"},{"issue":"11","key":"1832_CR83","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/mp.2013.194","volume":"19","author":"C Conejero-Goldberg","year":"2014","unstructured":"Conejero-Goldberg C, et al. APOE2 enhances neuroprotection against Alzheimer\u2019s disease through multiple molecular mechanisms. Mol Psychiatry. 2014;19(11):1243\u201350.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1832_CR84","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.nbd.2004.08.011","volume":"18","author":"BL Trommer","year":"2005","unstructured":"Trommer BL, et al. ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42. Neurobiol Dis. 2005;18(1):75\u201382.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1832_CR85","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3233\/JAD-2010-1348","volume":"20","author":"MJ Sharman","year":"2010","unstructured":"Sharman MJ, et al. Profiling brain and plasma lipids in human apoe \u03b52, \u03b53, and \u03b54 knock-in mice using electrospray ionization mass spectrometry. J Alzheimers Dis. 2010;20(1):105\u201311.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1832_CR86","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13195-019-0558-0","volume":"11","author":"I Lefterov","year":"2019","unstructured":"Lefterov I, et al. APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain. Alzheimers Res Ther. 2019;11(1):113.","journal-title":"Alzheimers Res Ther."},{"key":"1832_CR87","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jns.2004.11.037","volume":"229","author":"U Igbavboa","year":"2005","unstructured":"Igbavboa U, et al. Murine synaptosomal lipid raft protein and lipid composition are altered by expression of human apoE 3 and 4 and by increasing age.\u00a0J Neurol Sci. 2005;229:225\u201332.","journal-title":"J Neurol Sci"}],"updated-by":[{"DOI":"10.1186\/s12964-024-02004-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000}}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01832-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01832-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01832-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T04:02:15Z","timestamp":1735617735000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01832-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01832-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4789248\/v1","asserted-by":"object"}]},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12964-024-02004-y","URL":"https:\/\/doi.org\/10.1186\/s12964-024-02004-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"458"}}